Advanced Search
Contact | Corporate | Help

LCS12 vs. ENG Subdermal Implant (Nexplanon) Discontinuation Rate Study

Sponsors:
  • Bayer
Phases:
  • Phase III
IndicationsAcronym:
  • Contraception
Age Groups:
  • Adult
Gender:
Female
Names:
  • Drug: LNG-IUS (BAY 86-5028)
  • Drug: 68 mg etonorgestrel implant for subdermal use (Nexplanon)
Enrollment:
760

Additional information about NCT01397097.


SourceSolution © 2008-2012